Northwestern Medicine offers a healthy approach to weight loss with a full spectrum of care designed just for you. Weight management services include: Multidisciplinary teams of medical professionals; Personal weight loss plans and guidance at every stage; Nonsurgical and surgical weight loss treatment options; Pre and post-treatment support

Obesity. Too much body fat, especially if most of it is around the waist, increases the risk of developing heart disease and stroke. For adults, the body mass index (BMI) is a number that is used to define who is obese. The BMI is calculated using a person's weight and height. Higher BMI may indicate higher risk for obesity-related diseases.

Led by obesity medicine specialists who perform a comprehensive weight-focused history and evaluation. Using shared decision making, provide a treatment plan that incorporates lifestyle management and prescription of anti-obesity medications when indicated.

Jul 14, 2020 · A new Northwestern Medicine remote weight-loss program provides maximum weight loss for the lowest cost for people with obesity and does so with much less hassle than the gold-standard National Diabetes Prevention Program (DPP).

Jan 14, 2025 · Northwestern obesity expert is a commissioner on new international guidelines released today; Two new diagnostic categories of obesity introduced: clinical and pre-clinical obesity; New guidance says health insurance should cover clinical obesity without presence of another disease

Obesity is a serious, chronic disease that can inflict substantial harm to a person’s health. Learn about obesity causes and obesity health effects. ...more

Jan 15, 2025 · Clinical obesity is defined in the new guidelines as a chronic disease with specific signs and symptoms of ongoing organ dysfunction due to obesity alone. Treatment for clinical obesity — lifestyle, medication, surgery, etc. — should be aimed to fully regain or improve the body functions reduced by excess body fat, according to the report.

May 15, 2024 · CHICAGO --- A new Northwestern Medicine study shows that technology alone can’t replace the human touch to produce meaningful weight loss in obesity treatment.

The drug semaglutide, typically prescribed for treatment of Type 2 diabetes, was used in a phase 3 clinical trial as a treatment for obesity with very promising results. Northwestern's Robert Kushner, MD, led this study published in the New England Journal of …

Feb 11, 2021 · A new anti-obesity medication was shown to be almost twice as effective at helping individuals lose weight than some of the current weight-loss drugs on the market, according to a new landmark study conducted at Northwestern Medicine and other institutions and published in the New England Journal of Medicine.